Brad Morie is a Senior Director at Research Corporation Technologies, managing licensing of biotechnology platforms. He previously held business development and licensing roles at several life sciences companies.
At firms with a similar stage, sector and check size.
One email when Brad's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckBrad Morie is a Senior Director at Research Corporation Technologies, managing licensing of biotechnology platforms. He previously held business development and licensing roles at several life sciences companies.
Brad Morie invests through Research Corporation Technologies, which writes checks of $250K to $10M at pre-seed, seed, series a.
A warm intro from a founder Research Corporation Technologies backed works best.
Bus Dev Exec -Tech Transfer Division at Los Alamos National Laboratory; Director of BD & Marketing at BIOCRATES life sciences AG; Director, Business Development & Licensing at Lonza AG; Account Director, Business Development at Catalent Pharma Solutions; Member, Board of Advisors at Medigen USA.
Last updated 2026-10-15. Is this you? Ask for a correction.